Volume | 21,932 |
|
|||||
News | - | ||||||
Day High | 4.815 | Low High |
|||||
Day Low | 4.48 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
ZyVersa Therapeutics Inc | ZVSA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
4.71 | 4.48 | 4.815 | 4.41 | 4.75 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
397 | 21,932 | $ 4.60 | $ 100,985 | - | 3.94 - 141.89 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:59:02 | 30 | $ 4.72 | USD |
ZyVersa Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
27.97M | 1.24M | - | 0 | -106.25M | -85.46 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
ZyVersa Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ZVSA Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 3.95 | 5.30 | 3.95 | 4.88 | 186,613 | 0.46 | 11.65% |
1 Month | 5.18 | 5.52 | 3.94 | 4.81 | 80,441 | -0.77 | -14.86% |
3 Months | 7.865 | 10.20 | 3.94 | 6.86 | 500,230 | -3.46 | -43.93% |
6 Months | 12.30 | 25.00 | 3.94 | 9.33 | 1,653,580 | -7.89 | -64.15% |
1 Year | 136.885 | 141.89 | 3.94 | 40.73 | 3,172,512 | -132.48 | -96.78% |
3 Years | 4,900.00 | 5,232.50 | 3.94 | 87.50 | 2,476,292 | -4,895.59 | -99.91% |
5 Years | 4,900.00 | 5,232.50 | 3.94 | 87.50 | 2,476,292 | -4,895.59 | -99.91% |
ZyVersa Therapeutics Description
ZyVersa Therapeutics Inc is a clinical stage specialty biopharmaceutical company that leverages advanced proprietary technologies to develop and commercialize first-in-class prescription drugs. The company's focus is on restoring health and improving quality of life for patients with high unmet medical needs, with emphasis on inflammatory and renal diseases. |